Dilip Pandurang Pattil, Managing Partner, Trivector Biomed talks about the initiatives taken by Trivector Biomed and the plans for the Indian market

What role is Trivector Biomed playing to combat the COVID-19 pandemic?

Trivector Biomed has been working in the field of infection control with its innovative NanoStrike technology, since 2016. During COVID-19 pandemic, we got an opportunity to ramp-up awareness about hospital-acquired infection and airborne spread of SARS-COV2. We conducted and participated in multiple webinars to understand and analyse technology solutions offered to combat the spread of COVID-19. 

We have installed a few units of NanoStrike air-sterilisers at COVID hospitals including Kasturba Hospital, Saint George Hospital (Mumbai), Ram Manohar Lohiya Hospital in New Delhi and a few other Municipal Hospitals in Mumbai. These units were provided to them at free of cost and allowed us to receive feedback on its role in combating COVID-19. The hospitals have given positive feedback that these machines are keeping bio-burden in control and have been protecting the front line workers. 

And, we are not restricting this technology to hospitals alone but also offering these units on rental basis to individual patients as well as to offices, schools etc.

Tell us more about the ‘Nano-Strike’ patented plasma technology-based air disinfection units and what are its benefits?

NanoStrike is a unique and the only technology of its kind available for effectively disinfecting the air by killing the pathogens (Viruses, Bacteria, Fungi etc) in milliseconds. All other technologies that are available either trap the viral/bacterial particles or agglomerate them with ionisation or use by-product of plasma discharge or free radicals to deactivate pathogens.

NanoStrike Plasma technology has all the processes of deactivation (etching, electron bombardment, photon radiation, osmatic pressure etc) that happen around the plasma-coils, inside the machine and cell membrane burst. 

The whole process takes place in milliseconds and doesn’t allow microorganism to modify or replicate and only the disinfected air comes out, that is safe to be consumed by one and all. 

NanoStrike is green, clean and a silent technology that has been independently validated by more than 30 institutes in the world, including NASA.

How affordable are Novaerus air-disinfection units? In which hospitals have these units been set up?

NanoStrike range of air-disinfection units is a one-time investment with minimal life-cycle cost. They are a value for money product as there is no need to change the filter, cartridges, lamps or chemicals for that matter. Not just that, these units consume minimal electricity even when used 24X7.

As mentioned earlier, Trivector Biomed LLP has deployed these units in multiple hospitals in addition to Jaslok Hospital, Reliance Foundation’s HN Hospital in Mumbai,  BIRTH Fertility Clinic, Kolkata,  Patki Hospital, Kolhapur to name a few.

Novaerus units are also made available on easy rental plans, which enables many to afford and experience its benefits. 

Trivector has added two more verticals — Infection Control and Veterinary Biotechnology in 2016. How has been the journey so far for both the verticals?

Since the time we diversified into Infection Control and Veterinary Biotechnology in 2016, we have seen ups and downs. 

Before the outbreak of COVID-19, the awareness and acceptance for airborne infection was limited. Most of the healthcare establishments were in denial and reluctant to implement new technology solutions like NanoStrike. Post COVID-19, the acceptance level for innovative solutions such as ours has increased, but is facing a different challenge of financial crunch to buy new equipment. 

Talking about veterinary biotechnology, our experience of over 25 years in dealing with Human IVF is now helping us guide veterinarians to start Animal IVF labs to produce more indigenous breeds and increase the milk yield. Most of Veterinary Biotechnology work is being done by state-owned livestock development boards and veterinary universities, which are more research oriented. We are also providing hand-holding training to Indian veterinarians in collaboration with Danish and British scientists. 

What is the current business outlook for Sperm Bank – Baby Quest venture, which was launched way back in 2008? 

BabyQuest Cryobank was founded as a social service arm of Trivector Biomed in 2008 with the intention of providing best quality, medically tested semen samples to infertile patients. Over a period of time, we have created a niche for ourselves as a sperm bank of choice for the infertile couples and clinics across India. This activity hasn’t even broken even and we have been sustaining this activity inspite of mounting losses. 

The new ART Bill 2020, which was presented in the recent session of Parliament, if implemented as it is (with lots of anomalies), no sperm bank would be able to run in India. E.g. The Bill doesn’t allow to ‘sell’ sperm samples, doesn’t allow to pay donors, there is no anonymity clause, it stipulates to use a sample of one sperm donor to only one couple. With scarcity of Sperm Donors and strict selection criteria, it is not only impractical but would make the sperm banks unviable and expensive to run.  About half the infertile couples have male factors, which may need donor sperm, it becomes all the more important and necessary to discuss technicalities and ground realities and  pass a bill that allows sperm banks to grow and contribute in helping infertile couples.

What are your plans for the Indian market post COVID-19?

We have installed multiple NanoStrike units in government run hospitals and shown the utility and effectiveness of these units in controlling spread of diseases like COVID-19 and TB. 

We want the policy makers and institutes like ICMR, NABH and State Health departments to implement this life-saving unique technology across public hospitals. We are trying to make them affordable and available on demand. We are willing to enter into a Public-Private Partnership with such institutes to help control the infection with our solutions.

Tell us about your business model?

Our business model is based on three strategic vectors namely – Care, Commitment and Convenience. We supply the equipment for taking utmost care of patients at affordable prices. Our commitment to our customers to deliver whatever is promised in a shortest possible time (we keep adequate stock of all equipment to be able to supply on demand).

We provide convenience to the customers by making these solutions available and installed without hassle of maintenance or recurring costs and offer easy rental plans too.

Leave a Reply

Your email address will not be published. Required fields are marked *